Santos et al. (7) and Maia et al. (8) referenced OEAz chromatographic characteristics the herbal medicine with OEAz, used in this present study, as abundant in monoterpenes, terpinen-4-ol (37.62%), 1,8-cineole (17.58%), gamma terpene (11.77%) and para-cymene (10.67%). In your studies, Santos et al. (7) demonstrate that OEAz the herbal medicine OEAz modulated by dose dependent way the L-type Ca2+. Since 2006, OEAz has been investigated in spasticity modulation action with functional motor system gain in spasticity acute treatment (9; 10; 8) . The goal of this study was to assessment subacute and chronic treatment with herbal medicine OEAz associated with Kinesiotherapy on patient with muscle spasticity: cases series.
MATERIALS AND METHODS

Study Design and Participants
This research is about clinical cases study, monocentric, prospective, for convenience, cases series divided in child, teenagers and adults treated in specific periods, in subacute and chronic forms where the spasticity was the variant. This work complies with the principles laid down in the Declaration of Helsinki 2013, recommendations guiding physicians in biomedical research involving human subjects, and was approved by the local Committee on Ethics in Research with Human Beings (CAAE-# 56717516.1.0000.53).Activities were started after research project submission and respective approval by Ethics Committee. The selected volunteers were informed about study methodology, propose and consulted about participation interest. After read and having agreement, free informed consent form was signed.
Drug Treatment
The treatment was carried out with Alpinia zerumbet essential oil extracted by steam trawl and diluted in vegetable oil (33%). In cases of tetraparetic and hemiparetic commitment the doses were 0.05 mg/ 2Kg in and 0.05 mg/ 4Kg, respectively. The medication application site was the spasticity muscle, having the total dose per individual divided by these commitment muscles quantitative.
Procedures
Study groups were divided in subacute (from 11 to 35 applications; equivalent) and chronic (from 36 to 72 applications), to better evaluate medical effects in time line witch was measured in months, two (2) to six (6) . Duration treatment was equivalent to 1 hour, in alternate days of Kinesiotherapy associated to herbal medicine OEAz application. Exercise consisted in assisted axial, scapular and pelvic to dissociate waists to control movement exercise, appendicular selective movements exercise, and closed chain to get up from sitting, step and inverted bicycle exercise, for adults; or Kinesiotherapy for children (9) . Inclusions criteria was paresis and plegia associated with muscle spasticity due to Pyramidal Syndrome. Patient with dermatitis, dermic allergy and blood pressure of 100/60 mmHg were excluded, and witch did not agree to participate of the study. Tonus evaluation was by a MMAS (11) following the guidelines. The value, before and after the treatment following guidelines were: patient in supine and relaxed. Muscles were shortened and distended in maximum way in one (1) second. Scores punctuation was: 0 = None muscle tonus increase; 1 = Slightly muscle tonus increase, manifested as minimum resistance at the wide movement end, when the affected part is moved in flexion or extension; 1+ = Slightly muscle tonus increase, manifested as minimum resistance at the remaining movement amplitude, but the affected part (s) is (are) easily moved; 2 = More evident muscle tonus increase, manifested as most movement amplitude, however easily moved; 3 = Considered muscle tonus increase with hard passive movement during entire movement amplitude; and 4 = affected parts rigid in flexion or extension.
Statistical Analysis
Kolmogorov-Smirnov test was utilized to analyses studies variable normality. Groups presented in supposition of non-satisfactory normality, applying Wilcoxon Marched Pairs test for dependent paired groups and Kruskal-Wallis with Dunn's post test for three more groups. In every analyzes Ashworth scores were adjusting in numeric sequence due to 1+ that become 2 and successively the others scores, besides the significant level of 5% be considered.
RESULTS AND DISCUSSION
The results refer to tonus decrease of spastic patient treated with herbal medicine OEAz. Treatment time differed in two (2), three (3) four (4), five (5), six (6) and seven (7) months with propose of verify response to subacute and chronic treatment. Besides treatment pause for 6 months in a condition of 1, 2 months' treatment and condition of 7 months' treatment following by 6 months without treatment and after more 7 years without treatment (Figure 1 A, B, C, D, E In 1A figure, a 6 years old child volunteer was treated subacutely with 0.6 mL dose per 2 months' treatment getting significant tonic decrease in relation to treatment beginning (p < 0.05).In 1B and 1C figure, the following results are from a 12 years old patient treated chronically with herbal medicine OEAz (0.5 mL) for 3 months, significant difference (p< 0.01). When treated during for 4 months, also demonstrated significant relaxation (p< 0.01). Time without treatment was 1 month, reason why the results are separated. In 1D figure, results from 2 years old child treated with 0.5 mL dose for 5 months, it was obtained a significant result (p = 0.049). In 1E figure, the 16 years old teenager treated chronically with a 2.3 ml dose for 6 months presented significant results (p< 0.001). Figure 1F , hemiparetic adult treated for 2 months with 0.6 mL dose in spastic muscle. Results were also favorable revealing significant spasticity decrease after the treatment period (p < 0.001).Whereas the 1G figure refers to a patient treated with herbal medicine OEAz with time intervals without treatment. Child was 5 months' years old and when treated with 0.5 mL dose demonstrated significant tonic modulation in 1 month (p< 0.01) and 2 months (p< 0.001). However, when had a period without treatment, the hypertonic scores increase being the same as the 1ª evaluation. Lastly, on 1H figure, the patient was a 29 years old adult treated chronically with 1.3 mL dose during 7 months. Treatment results came up significant (p < 0.001) regarding hypertonia before treatment. After 6 months without treatment, when being evaluate, was observed that muscle relaxation continues, because did not have significant difference from after treatment tonic evaluation. After 7 years, it still has no spasticity.
On Figure 2 behavior over time and how spasticity presented its scores was demonstrated, before and after treatment. Every patient results were; regardless of age, severity at the start of treatment or cause of spasticity; evaluated separately by treatment time. Both mean and median demonstrated that the patients still have moderate spasticity, except an adult patient treated for 7 months. However, with expressive significant decrease of spasticity, the longest time regarding the others. On figure 3, spasticity scores after treatment were compare to bigger or smaller time treatment; taking the stratification in 5 months and 2 years old child (A), 6 to 16 years old child (B) and adult (C) into consideration treated for 7 months. Comparison were made after treatment. It was verifying significant spasticity decrease only in adults (p = 0.03). Although 6 to 16 years old child time be bigger than adults, it did not show significant difference between post treatment results, and in youngers child (5 months and 2 years) spasticity scores decreased, nevertheless with no significance.
Figure2. 2A figure presents the initials scores and 2B figure the finals scores times treatment by Modified
Results obtained from this study demonstrate that both subacute and chronic herbal medicine OEAz treatment decrease hypertonia significantly. Topic application is justified on the study basis of Cal (12) that presented, in vitro, better option in relation to others four terpenes types, besides better results in oil solution to hydrogel emulsion utilization, to be used as vehicles. Terpenes absorption read was realized at least 1 hour after its application, and its tissue absorption is from 10 to 20%. This application time and pharmacokinetics activity are also according to Khalil et al.(13) . Another justification given by the present study is that dermal application is easy to be topic, thus, directing the bioproduct on hyperactivity compromised muscleL-type Ca2+ (spastic). In research, Santos et al. (7) verify that OEAz (100%), same as utilized on Zicague® this study, significantly fast reduced L-type Ca2+, reversible and contraction dependent (25 and 250 µg/mL; p<0.05); thus justify, spasticity inhibition results obtained in every present study related case. L-type Ca2+ was recognized as altered in spastic muscle (4, 14, 15) and are responsible for passive tension that directly induce spasticity (16) besides increase muscle stiffness (17) . Muscle stiffness is pointed as increase spasticity cause (6) .Therefore, Cerqueira et al. (10) evidenced that OEAz, Dosed oil, was capable to revert collagen thickness and organization alteration in rats' subacute treatment (45 days of treatment) with spastic spine cord injury. The muscular weakness as it relates to stroke, is closely connected to inability and dependence. The should be applied activity in association to resisted, including aerobic exercise, functional training and supervised (18) . However, should be care fulling in cases of central lesion patients, because abnormal tonic reactions can be reinforcing on them and consequently increase spasticity. Justifying, therefore, Kinesiotherapy limitations on spastic individuals' treatment with for muscle strength goal. For Cândido and Xavier-Filho(9), Kinesiotherapy associate with OEAz, Dosed oil, acute treatment (1 month), in same dose as utilized in this study, also dermal applied in Cerebral Paralysis child, present significant effective results in spasticity decrease and functional gain. Even though it is already significantly, before and after treatment comparison, was noticed that after 6 months' treatment, the post treatment results, compared to each other, presents bigger spasticity scores decrease in relation to shorter treatment time. However, with 7 months had significant difference even bigger on spasticity decrease in relation to treatment second (2º), third (3º), fourth (4º) and fifth (5º) month.
CONCLUSIONS
The herbal medicine OEAz associated with Kinesiotherapy in different treatment times provided significant spasticity decrease, probably by L-type Ca2+ modulation. Also, 7 months and longer time be the most appropriate to better spasticity control, after longer treatment pause. It is necessary to continue researches, increase number of individuals treated for 7 months to verify repeat response founded in the present study.
